vaccine sales - The African Mirror

Jul

2021

Pfizer raises 2021 COVID-19 vaccine sales forecast to $33.5 billion

MANAS MISHRA and MICHAEL ERMAN PFIZER Inc has raised its full-year sales forecast for the COVID-19 vaccine it developed with Germany's BioNTech by 29% to $33.5 billion, as nations stock up on doses for the rest of the year. The company also said it could apply for an emergency use authorization for a potential booster dose as early as August, reiterating that a third shot will likely be needed to enhance protection amid a resurgence in infections in many countries. New early data showed that a third dose generated virus-neutralizing antibodies more than 5 times higher in younger people and…

May

2021

By The African Mirror

Pfizer bets on COVID-19 vaccine demand for years, sees sales of $26-billion in 2021

BUSINESS

MANAS MISHRA and MICHAEL ERMAN PFIZER Inc yesterday raised its forecast for 2021 COVID-19 vaccine sales by more than 70% to $26 billion and said demand from governments around the world trying to halt the pandemic could contribute to its growth for years to come. The company said it expects by the end of this month to file for full approval of the vaccine for people over the age of 16 in the United States, where it is currently only authorized for emergency use. It also expects to hear soon from U.S. regulators on the expansion of the vaccine's emergency…

Apr

2021

By The African Mirror

J&J reports $100 million in vaccine sales as results top forecasts

BUSINESS

JOHNSON & Johnson beat expectations for quarterly earnings and raised its dividend payouts to shareholders yesterday, while reporting $100 million in sales of its COVID-19 vaccine, whose use was paused by U.S. regulators last week. The company, which has previously said the vaccine will be available on a not-for-profit basis until the end of the pandemic, also tightened its forecast for adjusted profit this year, suggesting it was largely performing as previously expected. Use of the company's vaccine was temporarily halted by U.S. regulators as they investigate reports of blood clots in six women, prompting a similar pause in South…